Addressing Climate Change

Biotechnology is bringing us climate-smart technologies to recycle carbon, reduce greenhouse gas emissions and strengthen the resilience of agriculture and food production. Explore the resources and news updates on this page to learn BIO’s work for policy that allows biotech to reach its full potential as climate-tech.

Explore BIO's Impact at COP
member-benefits-ag

Discover how BIO is shaping the future at the Conference of the Parties (COP). Uncover our commitment to sustainability, innovation, and global collaboration in the biotech industry. Join us in navigating the intersection of science, policy, and environmental stewardship at COP.

Bold Goals for Biotechnology: Promoting continued innovation and progress in the bioeconomy

BIO wholeheartedly supports the Biden administration’s Executive Order and its related “Bold Goals for U.S. Biotechnology and Biomanufacturing.” We urge action to operationalize those goals.

BIO Resources
Scanning plants

BIO’s Climate Report

Examining biotechnology's contributions to addressing the climate crisis.

Climate Policy Innovation Series: Food & Ag Systems

Climate Policy Innovation Series: Food & Ag Systems

Discover policies backing agri-innovation for eco-friendly farming and secure food supply.

Biotech Crops Are Driving Global Solutions to Climate Change

Climate Policy Innovation Series: Fueling the Energy Transition

Discover effective regulations to drive innovation across tech stages: research, development, demo, and deployment.

BIO Advocate Toolkit

Top BIO News Stories on Climate

Read the latest Climate Change blogposts on BIO.news.

Earth Day

BIO/ICBA SDG Report

ICBA partners with its national authorities and international organizations to overcome global challenges.

News
small plants

BIO supports the Growing Climate Solutions Act (GCSA) (S. 1251/H.R. 2820), which will foster sustainability and economic resiliency in agriculture and preserve America’s rich environmental diversity.

 

Industrial plant

In recent years, America’s position as the global leader in new technologies has come under attack. As countries race to secure access to these technologies, governments are working to weaken global rules and international organizations, instead of investing in innovation.

Letters, Comments & Testimony
March 1, 2024
We are writing on behalf of the Biotechnology Innovation Organization (BIO) to provide comments on the Centers for Medicare & Medicaid Services’ Draft CY 2025 Part D Redesign Program Instructions.
March 1, 2024
CMS proposes updates to the RxHCC to reflect the impact of the new 2025 Part D benefit structure per the Inflation Reduction Act (IRA).
March 15, 2024
The Biotechnology Innovation Organization (BIO) appreciates the opportunity to comment on the U.S. Committee on Education and the Workforce’s (Committee’s) Request for Information on Reforms to Increase Affordability and Quality in Employer-Sponsored Health Coverage (ERISA RFI).